InsidersTradesSigma
Explore the detailed record of transactions filed by Heffernan Michael Thomas, Director. Officer active across 3 companies, notably Collegium Pharmaceutical, INC. Cumulatively, 5 disclosures have been published. The latest transaction was filed on 19 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Heffernan Michael Thomas is a Board Member at COLLEGIUM PHARMACEUTICAL, INC and Akebia Therapeutics, Inc. He brings valuable expertise in the pharmaceutical field. His role on the boards is to guide the growth and innovation strategies of these companies.